Eltrombopag
99%
- Product Code: 74004
CAS:
496775-61-2
| Molecular Weight: | 442.47 g./mol | Molecular Formula: | C₂₅H₂₂N₄O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20926253 | |
| Melting Point: | 242-244ºC | Boiling Point: | 656.8ºC |
| Density: | 1.33g/cm3 | Storage Condition: | room temperature, dry |
Product Description:
Eltrombopag is primarily used to treat thrombocytopenia, a condition characterized by low platelet counts, which can lead to increased bleeding and bruising. It is commonly prescribed for patients with chronic immune thrombocytopenia (ITP) who have not responded adequately to other treatments. Additionally, it is used in patients with hepatitis C to manage thrombocytopenia, enabling them to undergo interferon-based therapy. Eltrombopag is also effective in treating severe aplastic anemia by stimulating the production of blood cells, including platelets, in patients who are not eligible for bone marrow transplants. It works by mimicking the action of thrombopoietin, a natural protein that promotes platelet production in the bone marrow.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Orange to Red Powder,Solid,Crystals and/orChunks |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $70.60 |
+
-
|
| 1.000 | 10-20 days | $186.88 |
+
-
|
| 5.000 | 10-20 days | $560.64 |
+
-
|
| 25.000 | 10-20 days | $2,220.14 |
+
-
|
Eltrombopag
Eltrombopag is primarily used to treat thrombocytopenia, a condition characterized by low platelet counts, which can lead to increased bleeding and bruising. It is commonly prescribed for patients with chronic immune thrombocytopenia (ITP) who have not responded adequately to other treatments. Additionally, it is used in patients with hepatitis C to manage thrombocytopenia, enabling them to undergo interferon-based therapy. Eltrombopag is also effective in treating severe aplastic anemia by stimulating the production of blood cells, including platelets, in patients who are not eligible for bone marrow transplants. It works by mimicking the action of thrombopoietin, a natural protein that promotes platelet production in the bone marrow.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :